NCL News Archive
Thursday, June 22, 2017
BIO, June 19-22, 2017
The BIO International Convention brings together leaders in the biotechnology and pharmaceutical industries. NCL Sr. Scientist, Dr. Jennifer Grossman, will once again be representing the NCL at BIO this year. Request a meeting via the partnering app or stop by the NIH Exhibition Booth (Booth #5207).
For more information on this year’s BIO meeting, or to register, please visit: http://convention.bio.org/
Wednesday, June 7, 2017
Global Endotoxin Summit, June 5-7, 2017
The third annual Global Endotoxin Summit will take place June 5-7 in Annapolis, MD. NCL Senior Principal Scientist, Marina Dobrovolskaia, has been invited to discuss Detection and Quantification of Endotoxin in Engineered Nanomaterials and Nanotechnology-Formulated Drugs. Her talk will highlight the challenges associated with testing nanoparticles using the various LAL formats and discuss ways to overcome interference issues.
For more information and to register for the meeting, please visit: http://www.lonza.com/products-services/pharma-biotech/endotoxin-detection/endotoxin-detection-assays/global-endotoxin-testing-summit.aspx
Tuesday, June 6, 2017
American Society of Clinical Oncology, June 2-6, 2017
The American Society of Clinical Oncology (ASCO) meeting will be held in Chicago, IL, June 2-6. Pavan Adiseshaiah, NCL’s Cancer Biology Section Head, is planning to attend and speak. More details on his talk will be posted soon.
For more information and to register for the meeting, please visit: http://am.asco.org/
Saturday, May 27, 2017
National Congress of the Spanish Society of Immunology, May 25-27, 2017
The National Congress of the Spanish Society of Immunology conference is hosted in Zaragoza, Spain, and takes place May 25-27. Marina Dobrovolskaia, NCL Senior Principal Scientist and head of the Immunology Section, is an invited speaker at the event. Her talk will be Thursday May 25th, titled Immunological Properties of Nanotechnology-Based Complex Drug Formulations: Achievements, Disappointments and Lessons Learned from Preclinical Characterization.
Wednesday, May 24, 2017
FIP Pharmaceutical Sciences World Congress; May 21-24, 2017
NCL’s Director, Scott McNeil will be speaking at the 2017 FIP Pharmaceutical Sciences World Congress (PSWC) in Stockholm, Sweden. His talk, “The growing analytical toolbox for complex drugs : validation with clinical outcomes”, is scheduled for Wednesday May 24 in the Non-Biological Complex Drugs Session, taking place from 9 am – noon. Other speakers in the session include Stefan Muhlebach (University of Basel), Daan Crommelin (Utrecht University), Gerrit Borchard (University of Geneva), Falk Ehmann (European Medicines Agency), and Brian Min (Samsung Bioepis).
For more information and to register for the meeting, please visit: http://pswc2017.fip.org/
Wednesday, May 10, 2017
CLINAM, May 7-10, 2017
The annual CLINAM meeting will take place May 7-10 in Basel, Switzerland. NCL Director, Scott McNeil will be giving two talks during the meeting. The first will be a plenary lecture entitled “Nanomedicine Development: The Journey from Publication to Preclinical”, taking place on Monday, May 8th. This session, Future of Nanomedicines and Targeted Delivery-Status 2017, also include talks from Gert Storm (Utrecht University), Piotr Grodzinski (National Cancer Institute), and Omid Farokhzad (Harvard Medical School).
The second talk will be Tuesday, May 9th, in the Nano‐Targeting to Cells and Tissues: Mechanisms, Quantifying Deposition and Elimination session. Other speakers in this session include Tore Skotland (Oslo University), Kirsten Sandvig (University of Oslo), Andre Nel (University of California, Los Angeles), and Marco Siccardi (University of Liverpool).
For more information and to register for the meeting, please visit: https://www.clinam.org/
Thursday, April 6, 2017
International Advanced Drug Delivery Symposium; April 6-7, 2017
The 2017 International Advanced Drug Delivery Symposium (IADDS) will be held in Taipei, Taiwan, April 6-7, 2017. NCL’s Sr. Principal Scientist in Immunology will be speaking. Further details will be posted soon.
Wednesday, April 5, 2017
American Association for Cancer Research (AACR) Annual Meeting, April 1-5, 2017
This year’s AACR annual meeting will take place April 1-5, 2017, at the Walter E. Washington Convention Center in Washington, DC. NCL Sr. Scientist Dr. Jennifer Grossman will be speaking at an NCI-sponsored session on “Resources at the Frederick National Lab for Cancer Research”. If you have questions about how the NCL testing program works, what resources are available, or whether or not your technology would be a good fit for NCL, Jennifer will be available to answer questions.
For more information on this year’s AACR meeting, or to register, please visit:
Monday, March 20, 2017
USP Workshop: Nanomedicines – Technical and Regulatory Perspectives; March 20-22, 2017
The United States Pharmacopeia (USP), along with co-sponsors AAPS and FIP, is hosting a three-day workshop on the technical and regulatory perspectives of nanomedicines. The meeting will be held March 20-22, 2017 in Rockville, MD. The draft agenda has been posted and includes global speakers from industry, academia, various government organizations. NCL’s Director Scott McNeil is slated to speak on day two of meeting and will discuss analytical challenges and advances in nanomedicine characterization.
For more information, please visit: http://www.usp.org/meetings-courses/workshops/nanomedicines-technical-and-regulatory-perspectives
Sunday, March 12, 2017
Society of Toxicology Annual Meeting; March 12-16, 2017
The 2017 SOT Annual Meeting and Tox Expo will be held in Baltimore, MD. Several staff members from the NCL will be attending, including Dr. Stephan Stern, NCL’s Pharmacology & Toxicology Sr. Principal Scientist. Details about NCL talk and poster times will be posted as soon as they’re available.
For more information and to register for the meeting, please visit: http://www.toxicology.org/events/am/AM2017/